4 курс / Акушерство и гинекология / Диссертация_Агрба_И_Б_Органосохраняющее_хирургическое_лечение_родильниц

131

Res Clin Obstet Gynaecol.- 2014.- №28(3).- Р.429-42.

72.D’Antonio F, Iacovella C, Bhide A. Prenatal identification of invasivу placentation using ultrasound: systematic review and meta-analysis // Ultrasound Obstet Gynecol.- 2013.- №42(5).- Р.509-17.

73.Damsky CH, Librach D, Lim K-H, et al. Integrin switching regulates normal trophoblast invasion // Development.-1994.- №120.- Р.3657–3666.

74.De Lange M, Rouse GA. Ob/Gyn Sonography: An Illustrated Review. Pasadena, Calif: Davies Publishing Inc.- 2004.

75.De Vries C, Escobedo J, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor // Science.- 1992.- №255.- Р.989-91.

76.Decuypere JP, Parys JB, Bultynck G. Regulation of the autophagic bcl-2/ beclin 1 interaction // Cells.- 2012.- №6;1(3).- Р.284-312.

77.Department of Reproductive Health and Research, World Health Organisation. Maternal mortality in 2000: estimates developed by WHO, UNICEF and UNFPA. Geneva: WHO.- 2004.

78.Deshpande NA, Carusi DA. Uterine rupture after prior conservative management of placenta accreta // Obstet Gynecol.-2013.- №2.-Р.475-8.

79.Dreux S, Salomon LJ, Muller F, Goffinet F, Oury JF; ABA Study Group, Sentilhes L. Second-trimester maternal serum markers and placenta accreta. // Prenat Diagn.-2012.- №107-Р.1010-2.

80.Deshpande NA, Carusi DA. Uterine rupture after prior conservative management of placenta accreta // Obstet Gynecol.-2013.- №122.- Р.475-8.

81.Deux JF, Bazot M, Le Blanche AF et al. Is selective embolization of uterine arteries a safe alternative to hysterectomy in patients with postpartum hemorrhage? // AJR Am J Roentgenol.- 2001.-№177.-Р. 145-149.

82.Dreux S, Salomon LJ, Muller F, Goffinet F, Oury JF; ABA Study Group, Sentilhes L. Second-trimester maternal serum markers and placenta accreta // Prenat Diagn.- 2012.- №32(10).- Р.1010-2.

83.Dwyer BK, Belogolovkin V, Tran L. Prenatal diagnosis of placenta accreta: sonography or magnetic resonance imaging? // J Ultrasound Med.-2008.- №27(9).- Р.1275-81.

84.Earl U, Bulmer JN, Briones A. Plcenta accreta: an immunohistological study of trophoblast populations // Placenta.-1987.- №8.- Р.273-82.

85.Enholm B, Jussila L, Karkkainen M, Alitano K. Vascular endothelial growth factor C: a growth factor for lymphatic and blood vascular endothelial cells

//Trends Cardiovasc Med.-1998.- №8.- Р.292-7.

86.Felmeden DC, Blann AD, Lip GYH. Angiogenesis: basic pathophysiology and implications for disease // Eur Heart J.-2003.- №24- Р.118-22.

87.Finberg HJ, Williams JW. Placenta accreta: prospective sonographic diagnosis in patients with placenta previa and prior caesarean section // J Ultrasound

132

Med.-1992.- №11.- Р.333–43.

88.Floridon C, Nielsen O, Holund B, Localization and significance of urokinase plasminogen activator and its receptor in placental tissue from intrauterine, ectopic and molar pregnancies // Placenta. -1999.- №20(8).-Р.711-21.

89.Fox H. Placenta accreta, 1945–1969// Obstet Gynecol Surv.- 1972.-№7.- Р.475–90.

90.Frank HG, Kaufmann P. Nonvillous parts and trophoblast invasion. In: Benirscheke K, Kaufmann P (eds) // Pathology of the Human Placenta, 4th edn. Springer: New York.- 2000.- Р. 171–272.

91.Hadjinicolaou AV, Wu L, Fang B, Watson PA, Hall FC, Busch R. Relationship of CD146 expression to activation of circulating T cells: exploratory studies in healthy donors and patients with connective tissue diseases // Clin Exp Immunol.- 2013.- №174(1).-Р.73-88.

92.Harma M, Gungen N, Ozturk A. B-Lynch uterine compression suture for postpartum haemorrhage due to placenta praevia accreta // Aust N Z J Obstet Gynaecol.-2005.- №45.- Р.93-5.

93.Hata K, Udagawa J, Fujiwaki R, Nakayama K, Otani H, Miyazaki K. Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancer // Oncology.-2002.- №62.- Р.340-8.

94.Hauser S, Weich HA. A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta // Growth Factors.-1993.-№9.- Р.259-68.

95.Helske S, Vuorela P, Carpeґn O, Hornig C, Weich H, Halmesmaki E. Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies // Mol Hum Reprod.- 2001.-№7.- Р.20510.

96.Hollander DI, Pupkin MJ, Crenshaw MC, et al. Conservative management of placenta accreta. A case report // J Reprod Med.-1998.- №33.- Р.74–8.

97.Hwu YM, Chen CP, Chen HS, et al. Parallel vertical compression sutures: a technique to control bleeding from placenta praevia or accreta during caesarean section // BJOG.- 2005.- №112.- Р.1420-3.

98.Islami D, mock P,Bischof P. Effects of human chorionic gonadotropin on trophoblast invasion // Semin Reprod Med.-2001.- №19.- Р.49-53.

99.Jenn J. Tseng, MD, Shih L. Hsu, PhD, Esther Shih C. Differential expression of angiopoietin-1, angiopoietin-2, and Tie receptors in placentas from pregnancies complicated by placenta accreta //American Journal of Obstetrics and Gynecology.-2005.-№4-Р.193-6.

100.Ji un-Lung Liang, Pao-Chu Yu, Hsin-You Ou, et al. Intraoperative Uterine Artery Embolization in Two Patients with Placenta Previa Accreta: comparison of two approaches to controlbleeding // Radiol.- 2009.- № 34.- Р. 227-23.

101.Jiang B, Zhang Z, Zheng P, Ju L, Tang K, Lou Y. Apoptotic genes

133

expression in placenta of clubfoot-like fetus pregnant rats // Int J Clin Exp Pathol.- 2014.-№7(2).- Р.677-84.

102.Jokhi PP, King A, Loke YW. Reciprocal expression of epidermal growth factor receptor (EGF-R) and c-erbB2 by non-invasive and invasive human trophoblast populations //Cytokine .-1994.-№6.- Р.433–442.

103.Joshi VM, Shrivastava M. Partial ischemic necrosis of the uterus following uterine brace compression suture // BJOG.-2004.- №111.- Р.279-80.

104.Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E. A novel vascular endothelial growth factor, VEGF-C, is the ligand for the Flt-4 (VEGFR-

3)and KDR (VEGFR-2) receptor tyrosine kinases //EMBO J.- 1996.- №15.- Р.290-

8.

105.Jurkovic D. Cesarean scar pregnancy and placenta accreta // Ultrasound Obstet Gynecol.- 2014.- №43(4).- Р.361-2.

106.Kassem GA, Alzahrani AK. Maternal and neonatal outcomes of placenta previa and placenta accreta: three years of experience with a two-consultant approach // Int J Womens Health.- 2013.- №28(5).- Р.803-10.

107.Kayem G., Davy C., Goffinet F. Conservative versus extirpative management in cases of placenta accreta // Obstetrics and Gynecology.- 2004.-№3.- Р.531–536.

108.Khan M, Sachdeva P, Arora R, Bhasin S. Conservative management of morbidly adherant placenta - a case report and review of literature // Placenta. - 2013.-№34(10)-Р.963-6.

109.Khong T.Y., Abdul Rahman H. Bcl-2 expression delays postpartum involution of pregnancy-induced vascular changes in the human placental bed // Int J Gynecol Pathol.- 1997.- №16(2).- Р.138-42.

110.Kim TH, Lee HH. Conservative management of abnormally invasive placenta after vaginal delivery // Acta Obstet Gynecol Scand.-2014.- №93(1).- Р.123- 4.

111.Kliman H.Trophoblast infiltration // Reproductive Medicine Review.- 1994.- №3.- Р.137-157.

112.Knowles D. Neoplastic hemapathology. Lippincott. Williams and Wilkins.-2001.- Р.161.

113.Kumazaki K, Nakayama M, Suehara N, Wada Y. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathological conditions // Hum Pathol.- 2002.- №33.- 1069-77.

114.Lessey B.A. Adhesion molecules and implantation // J.Reprod.Immunol. -2002.-№55(1-2).- Р.101-112.

115.Lopata A, Bentin-Ley U, Enders A: ”Pinopodes” and Implantation // Reviews in Endocrine & metabolic Disorders.-2002.- №3.- Р.77-86.

116.Lin WC, Li AF, Chi CW, Chung WW, Huang CL, Lui WY. Tie-1 protein

134

tyrosine kinase: a novel independent prognostic marker for gastric cancer // Clin Cancer Res.-1999.-№5.- Р.1745-51.

117.Maglione D, Guerriero V, Viglietto G. Two alternative mRNA coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14 // Oncogene.-1993.- №8.-Р.925-31.

118.Maher MA, Abdelaziz A, Bazeed MF. Diagnostic accuracy of ultrasound and MRI in the prenatal diagnosis of placenta accreta // Acta Obstet Gynecol Scand. -2013.- №92(9).- Р.1017-22.

119.Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, et al. Angiopoietin-2, a natural antagonist for tie-2 that disrupts in vivo angiogenesis //Science.-1997.- №277.- Р.55-60.

120.Malassine A, Cronier L. Hormones and human trophoblast differentiation: a review // Endocrine.-2002.-№19.- Р.3-11.

121.Maldjian C, Adam R, Pelosi M, et al. MRI appearance of placenta percreta and placenta previa // Obstetrical & Gynecological Survey.-2000.- №55(3).- Р.131132.

122.Matsunaga T, Warltier DC, Tessmer J, Weihrauch D, Simons M, Chilian WM. Expression of VEGF, angiopoietins-1 and -2 during ischemia-induced coronary angiogenesis // Am J Physiol Heart Circ Physiol.- 2003.- №285.-Р.352-8.

123.Matsumura N, Inoue T, Fukuoka M. Changes in the serum levels of human chorionic gonadotrophin and the pulsatility index of uterine arteries during conservative management of retained adherent placenta // J Obstet Gynaecol Res.- 2000.- №26.-Р.81–7.

124.Marchetti D, Vellone V, Dhimitri O, Fulcheri E. Post-partum hemorrhage and malpractice claims: What can we learn from the findings of placental examination and endometrial curettage? A retrospective analysis of surgical pathology reports /

/Med Sci Law.-2014.-№54(2) -Р.99-104.

125.Maruo T, Matsuo H, Otani T. Role of epidermal growth factor (EGF) and its receptor in the development of the human placenta // Reprod fertile Dev.- 1995.- №7.- Р.1465-70.

126.Meng X, Xie L, Song W. Comparing the diagnostic value of ultrasound and magnetic resonance imaging for placenta accreta: a systematic review and metaanalysis // Ultrasound Med Biol. -2013.- №39(11).- Р. 1958-65.

127.Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previaplacenta accreta // Am J Obstet Gynecol. -1997.- №177.- Р. 210-4.

128.Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant // Nature.- 1994.- №367.- Р.576-9.

129.Mochizuki M, Mauro T, Matsuo H. Biology of human trophoblast // Int J Gynaecol Obstet.-1998.-№60.-Р.21-8.

130.Muhlhauser J, Crescimanno C, Kaufmann P, HoЁыer H, Zaccheo D,

135

Castellucci M. Diыerentiation and proliferation patterns in human trophoblast revealed by c-erbB-2 oncogene product and EGF-R // J Histochem Cytochem.- 1993.- №41.- Р.165-73.

131.Naruse K, Lash GE, Bulmer JN, Innes BA, Otun HA, Searle RF, Robson SC. The urokinase plasminogen activator (uPA) system in uterine natural killer cells in the placental bed during early pregnancy // Placenta.- 2009.- №30(5).- Р.398404.

132.Norwitz ER, Schust DJ, Fisher SJ: Implantation and the survival of early pregnancy // N Engl J Med.- 2001.- №345.- Р.1400-1408.

133.Ochoa M, Allaire AD, Stitely ML. Pyometria after hemostatic square suture technique // Obstet Gynecol.-2002.- №99.- Р.506-9.

134.Ohlsson R. Growth factors, protooncogenes and human placental development // Cell Diыer Dev.-1989.-№28.-Р.1-15.

135.Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa

//Obstet Gynecol.- 2006.-№107.-Р.927-41.

136.Palacios-Jaraquemada JM. Efficacy of surgical techniques to control obstetric hemorrhage: analysis of 539 cases //Acta Obstet Gynecol Scand.- 2011.- №12. 170-82.

137.Partanen J, Dumont D. Functions of Tie1 and Tie2 receptor tyrosine kinases in vascular development. Vascular growth factors and angiogenesis. Berlin: Springer-Verlag.-1999.-Р.159-72.

138.Pijnenborg R, Anthony J, Davey DA, Rees et al Placental bed spiral arteries in the hypertensive disorders of pregnancy // BJOG.-1991.- №98.- Р.64855.

139.Price N, B-Lynch C. Technical description of B-Lynch suture for treatment of massive postpartum hemorrhage and review of published cases // Int J Fertil.-2005.- №50.- Р.148-63.

140.Peker N, Turan V, Ergenoglu M, Yeniel O, Sever A, Kazandi M, Zekioglu O. Assessment of total placenta previa by magnetic resonance imaging and ultrasonography to detect placenta accreta and its variants // Ginekol Pol.- 2013.- №3.- Р.186-92.

141.Pelage JP, Le Dref O, Jacob D, et al. Selective arterial embolization of the uterine arteries in the management of intractable post-partum hemorrhage // Acta Obstet Gynecol Scand.-1999.- №78.- Р. 698-703.

142.Riggs JC, Jahshan A, Schiavello HJ. Alternative conservative management of placenta accreta // J Reprod Med.- 2000.- №45.- Р.595–598.

143.Rossipal E, Krachler M, Li F, Micetic-Turk D. Investigation of the transport of trace elements across barriers in humans: studies of placental and mammary transfer // Acta Paediatr.-2000.-№89(10).-Р.1190-5.

144.Rowe AJ, Wulы C, Fraser HM. Localization of mRNA for vascular endothelial growth factor (VEGF), angiopoietins and their receptors during the

136

periimplantation period and early pregnancy in marmosets // Reproduction.-2003.- №126.- Р.227-38.

145.Scarantino SE, Reilly JG, Moretti ML, et al. Argon beam coagulation in the management of placenta accreta // Obstet Gynecol.-1999.- №94.- Р. 825–7.

146.Sentilhes L , Ambroselli C., Kayem G. et al., “Maternal outcome after conservative treatment of placenta accreta // Obstetrics and Gynecology.- 2010.-

№3.-Р. 526–534.

147.Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis // J Biochem Mol Biol. -2006.- №30.- Р.469-78.

148.Shih IM. The role of CD146 (Mel-CAM) in biology and pathology // J Pathol.-1999.- №189.- Р.4–11.

149.Shih IM, Kurman RJ. The pathology of intermediate trophoblastic tumors and tumor-like lesions // Int J Gynecol Pathol.-2001.- №20.- Р.31–47.

150.Shih IM, Kurman RJ. Expression of melanoma cell adhesion molecule in intermediate trophoblast // Lab Invest.-1996.-№75.-Р.377–388.

151.Shih IM, Kurman RJ. Ki-67 labeling index in the differential diagnosis of exaggerated placental site, placental site trophoblastic tumor, and choriocarcinoma: a double immunohistochemical staining technique using Ki-67 and Mel-CAM antibodies // Hum Pathol.-1998.- №29.-Р.27–33.

152.Shkurupiy VA, Dubinin EV, Dubinina NN., Dynamics of myocytes of different types in rat myometrium during pregnancy and early postpartum involution // Bull Exp Biol Med.-2008.-№146(6).- Р.849-52.

153.Sofiah S, Late Y C Fung Placenta Accreta: Clinical Risk Factors, Accuracy of Antenatal Diagnosis and Effect on Pregnancy Outcome // Med J Malaysia.- 2009.-№4.- Р.298-302.

154.Sentilhes L, Goffinet F, Kayem G. Management of placenta accreta // Acta Obstet Gynecol Scand.-2013.- №10.- Р.1125-34.

155.Sonin A. Nonoperative treatment of placenta percreta //American Journal of Roentgenology.- 2001.- №177.- Р.1301-1303.

156.Staun-Ram E, Shalev E, Human trophoblast function during the implantation process // Reproductive Biology and Endocrinology.-2005.-№3.-Р.56- 8.

157.Taipale P, Orden MR, Berg M. Prenatal diagnosis of placenta accreta and percreta with ultrasonography, color Doppler, and magnetic resonance imaging // Obstet Gynecol.-2004.-№104(3).- Р.537-540.

158.Talamentes A, Ogren L. The placenta as an endocrine organ: polypeptides. In: Knobil E, Neill J, editors. The physiology of reproduction. New York: Raven Press.-1988.- Р.144.

159.Taylor AA, Sanusi FA, Riddle AF. Expectant management of placenta accreta following stillbirth at term: a case report // Eur J Obstet Gynecol Reprod

137

Biol.- 2001.-№96.- Р.220–2.

160.Teichert-Kuliszewska K, Maisonpierre PC, Jones N, Campbell AI, Master Z, Bendeck MP. Biological action of angiopoietin-2 in a ыbrin matrix model of angiogenesis is associated with activation of Tie-2. // Cardiovasc Res.-2001.- №49.- Р.659-70.

161.Terman BI, Dougher-Vermazen M, Carrion M, Dimitrov D,Armellino DC, Gospodarowicz D, et al. Identiыcation of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor // Biochem Biophys Res Commun.-1992.- №187.- Р.1579-86.

162.Timmermans S, van Hof A C, Duvekot J J. Conservative management of abnormally invasive placentation // Obstetrical and Gynecological Survey.-2007.- №62(8).- Р.529-539.

163.Treloar EJ, Anderson RS, Andrews HS, et al. Uterine necrosis following B-Lynch suture for primary postpartum haemorrhage // BJOG.- 2006.- №113.- Р.486-8.

164.Tseng JJ . Diыerential Expression of Vascular Endothelial Growth Factor, Placenta Growth Factor and Their Receptors in Placentae from Pregnancies Complicated by Placenta Accreta // Taiwan J Obstet Gynecol.- 2013.- №3.- Р.51-8.

165.Tseng JJ, Chou MM. Differential expression of growth-, angiogenesisand invasion-related factors in the development of placenta accreta // Taiwan J Obstet Gynecol. -2006.- №45.-Р.100-6.

166.Tseng JJ, Hsu SL, Ho ES, Hsieh YT, Wen MC, Chou MM. Differential expression of angiopoietin-1, angiopoietin-2, and Tie receptors in placentas from pregnancies complicated by placenta accreta // Am J Obstet Gynecol.- 2006.- №194(2).- Р.564-71.

167.Tsivos D., Malik F., Arambage K., Hagan P., Lee C. A life threatening uterine inversion and massive post partum hemorrhage caused by placenta accrete during Caesarean section in a primigravida: a case report //Case J.- 2009.- 2.- №138.- Р.138-43.

168.Uhrin P, Breuss JM. uPAR: a modulator of VEGF-induced angiogenesis

//Cell Adh Migr.-2013.-№7.-Р.23-6.

169.Usta I, Hobeika E, Musa A, Gabriel G, Nassar A. Placenta previa-accreta: risk factors and complications //American Journal of Obstetrics and Gynecology.- 2005.-№193(3).- Р.1045-1049.

170.UszyDski W, UszyDski M. Placenta accreta: epidemiology, molecular mechanism (hypothesis) and some clinical remarks // Ginekol Pol.- 2004.- №75.- Р. 971-8.

171.Valdis G, Neves LA, Anton L, Corthorn J, Chacуn C, Germain AM, Merrill DC, Ferrario CM, Sarao R, Penninger J, Brosnihan KB. Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies. Placenta.-2006.- №2-3.-Р.200-7.

138

172.Vigano P, Mangioni S, Pompei F, Chiodo I: Maternal-conceptus Cross Talk – A Review // Placenta.- 2003.-№ 24.- Р.56-61.

173.Vuorela P, Carpeґn O, Tulppala M, Halmesmaki E. VEGF, its receptors and the Tie receptors in recurrent miscarriage // Mol Hum Reprod.- 2000.- №6.- Р.276-82. 174.Xu G, Guimond MJ, Chakraborty Cet al. Control of proliferation, migration, and invasiveness of human extravillous trophoblast by decorin, a decidual product // Biol Reprod.-2002.-№67.- Р. 681-689.

175.Young BC, Nadel A, Kaimal A. Does previa location matter? Surgical morbidity associated with location of a placenta previa // J Perinatol.-2014.-34.- Р.264-7.

176.Wang P, Luo Y, Duan H, Xing S, Zhang J, Lu D, Feng J, Yang D, Song L, Yan X. MicroRNA 329 suppresses angiogenesis by targeting CD146 // Mol Cell Biol.-2013.-№33.-Р.3689-99.

177.Warshak CR, Eskander R, Hull AD. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta // Obstet Gynecol.- 2006.-№108.- Р.573-81.

178.Wohlmuth CT, Gumbs J, Quebral-Ivie J. B-Lynch suture: a case series /

/Int J Fertil Womens Med.-2005.-№50.- Р.167-73.

179.Wulff C, Wilson H, Dickson SE, Wiegand SJ, Fraser HM. Hemochorial placentation in the primate: expression of vascular endothelial growth factor, angiopoietins, and their receptors throughout pregnancy // Biol Reprod.-2002.- №66.- Р.802-1.

180.Zygmunt M, Herr F, Keller-Schoenwetter S. Characterization of human chorionic gonadotropin as novel angiogenic factor // J Clin Endocrinol Metab.- 2002.-№87.- Р.5290-6.

139